Replies to post #309931 on Avid Bioservices Inc (CDMO)

[biopharm]

Geo you should read all about it and the specific research where Dr Jedd Wolchok mentions PS Targeting is below:

"PSTargeting+Adoptive TCell Transfer (ACT) Eliminates Adv. Tumors w/o Off-Target Toxicities, Melanoma"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130490016

Many will follow Dr Jedd Wolchok and with MSK being founding member of Parker Cancer Institute, I imagine Sean Parker will want to limit off target TOXICITIES, increase responders and to also follow Dr Jedd Wolchok where one swift announcement could bring PS Targeting into the PCI Network where all share in the profits.

One can see each member party below

MSK, Stanford, UCLA, UCSF, Univ of Pennsylvania, MD Anderson......and added Icahn and Washington University in ST LOUIS, MO

https://www.parkerici.org/member-directory/?center=374